RxDoctor Payments Data

Sara Mueller

Family · New Castle, INNPI 1811348105

Payments from drug & device makers

$2,972in general payments, 2019–2025

Across 203 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$794
  • Novo Nordisk$558
  • Lilly USA, LLC$306
  • Bayer$192
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142
  • Pfizer$129
  • plus $851 from 20 others

What the payments were for

  • Food & beverage$2,972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,972 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$60,879
JardianceEmpagliflozin55$51,262
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$24,317
RybelsusSemaglutide16$17,735
FarxigaDapagliflozin Propanediol20$14,500
EliquisApixaban14$11,889
LinzessLinaclotide15$9,063
JanuviaSitagliptin Phosphate11$8,310
Breo ElliptaFluticasone/Vilanterol11$4,371
Albuterol Sulfate HfaAlbuterol Sulfate66$1,587
Pregabalin33$1,220
Oxcarbazepine11$1,184
Mirtazapine22$1,108
CholestyramineCholestyramine (With Sugar)11$1,084
Omeprazole71$918

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$558$78,61467 claims
Boehringer IngelheimJardiance$116$51,26255 claims
GSKTrelegy Ellipta, Breo Ellipta$95$28,68840 claims
AstraZenecaFarxiga$85$14,50020 claims
PfizerEliquis$129$11,88914 claims
AbbVieLinzess, Synthroid$794$9,58126 claims
Lilly USA, LLCOlanzapine$306$43924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in New Castle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →